The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study
about
Cost-Effectiveness of Dengue Vaccination Programs in BrazilSeroprevalence of antibodies to dengue and chikungunya viruses in Thailand.The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits.An economic evaluation of vector control in the age of a dengue vaccineImmune correlates of protection for dengue: State of the art and research agenda.Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination.A recombinant live attenuated tetravalent vaccine for the prevention of dengue.Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development.Garlic Organosulfur Compounds Reduce Inflammation and Oxidative Stress during Dengue Virus Infection.Using Wolbachia for Dengue Control: Insights from Modelling.Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination.Resource Use and Costs of Dengue: Analysis of Data from Phase III Efficacy Studies of a Tetravalent Dengue Vaccine.Seroprevalence of Dengue Antibodies in Three Urban Settings in Yucatan, Mexico.Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.Challenges in dengue research: A computational perspective.Contributions from the silent majority dominate dengue virus transmission.Transmission-clearance trade-offs indicate that dengue virulence evolution depends on epidemiological context.Forecasting the effectiveness of indoor residual spraying for reducing dengue burdenImplementing a dengue vaccination programme-who, where and how?Dengue virus serotype distribution based on serological evidence in pediatric urban population in IndonesiaStratified sero-prevalence revealed overall high disease burden of dengue but suboptimal immunity in younger age groups in Pune, IndiaRefined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learningA conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancementReconstruction of antibody dynamics and infection histories to evaluate dengue risk
P2860
Q33636857-C06A4C8B-F202-4CE2-8E85-E6FA462C7D2FQ33853736-07CD539D-7D14-40EF-89F1-0B23FE4AF0FEQ36206719-7D56F8E5-9B60-4DC3-AD32-5A7201FC60A6Q38156746-AF64BD73-5DA0-48BD-9F86-6867EADE4712Q38652971-A9F657BF-AAE8-45BD-AB1C-04D2B1C469C0Q38734455-5D1DCFEF-9139-4B6F-A718-7C9730803370Q38738484-8575DC73-99FC-44D8-9C26-CCDAAB408F05Q39535403-E51D8CF0-A3ED-4910-9EC9-D7D592D0DE45Q40051356-A7659CF5-14A4-4B48-AF42-07B9D4D7D194Q45880802-90C28C01-7322-4B64-B011-A9FF7E23168BQ47115918-55BF2144-A9E3-44A1-8833-5644D3BA708CQ47216541-5EEFD1DD-8F26-4009-A0A1-349624614186Q49820319-18F7CA91-A850-43BA-BE31-FB48472E8EEEQ52662743-F0492E45-22D7-42D9-AAF0-8336E480B20AQ54238236-5A1433A5-B128-4888-B8D8-AD4B5106EF27Q55119556-82934BC8-DB15-4E25-8984-71FDDA72C485Q55333503-A1B6473B-9608-4D08-8D19-097557994DACQ56353070-14F21A77-1DBD-4E4B-A8D4-4A0B3E3EE401Q56396529-F9A033E2-81D5-4279-ADEA-E562F9CD56AAQ56476041-26861E83-0749-425C-BC98-01BC96F08D1FQ57940620-EB24AF6B-4FE9-4552-BC43-4D9A9D095A40Q58759739-13D6B595-9FD6-49C8-AE98-B73E82130E95Q58769644-ED37DA03-8F1F-4478-A756-53D8261DD53DQ59055979-B325568F-7196-4712-BF83-1FA8F9D618D0
P2860
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The Long-Term Safety, Public H ...... xia): A Model Comparison Study
@ast
The Long-Term Safety, Public H ...... xia): A Model Comparison Study
@en
type
label
The Long-Term Safety, Public H ...... xia): A Model Comparison Study
@ast
The Long-Term Safety, Public H ...... xia): A Model Comparison Study
@en
prefLabel
The Long-Term Safety, Public H ...... xia): A Model Comparison Study
@ast
The Long-Term Safety, Public H ...... xia): A Model Comparison Study
@en
P2093
P2860
P50
P921
P1433
P1476
The Long-Term Safety, Public H ...... xia): A Model Comparison Study
@en
P2093
Ira Longini
Katia Koelle
Kirsten Vannice
Laurent Coudeville
Luis Mier-Y-Terán-Romero
Robert C Reiner
T Alex Perkins
P2860
P304
P356
10.1371/JOURNAL.PMED.1002181
P407
P50
P577
2016-11-29T00:00:00Z